Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04178-x
Abstract: This study aimed to examine the association between the trough plasma concentration of lenvatinib with the objective response rate (ORR) and adverse events in patients with hepatocellular carcinoma (HCC). Twenty-one patients with HCC who received… read more here.
Keywords: ctrough median; response; group; adverse events ... See more keywords